JP2021019642A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021019642A5 JP2021019642A5 JP2020184527A JP2020184527A JP2021019642A5 JP 2021019642 A5 JP2021019642 A5 JP 2021019642A5 JP 2020184527 A JP2020184527 A JP 2020184527A JP 2020184527 A JP2020184527 A JP 2020184527A JP 2021019642 A5 JP2021019642 A5 JP 2021019642A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- amino acid
- acid sequence
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 10
- 210000004962 mammalian cell Anatomy 0.000 claims 6
- 108091033319 polynucleotide Proteins 0.000 claims 6
- 102000040430 polynucleotide Human genes 0.000 claims 6
- 239000002157 polynucleotide Substances 0.000 claims 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 5
- 108020004414 DNA Proteins 0.000 claims 3
- 102000053602 DNA Human genes 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762508510P | 2017-05-19 | 2017-05-19 | |
| US62/508,510 | 2017-05-19 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511876A Division JP6790304B2 (ja) | 2017-05-19 | 2018-05-11 | Ｂｔｌａアゴニスト抗体およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021019642A JP2021019642A (ja) | 2021-02-18 |
| JP2021019642A5 true JP2021019642A5 (https=) | 2021-07-26 |
| JP7072622B2 JP7072622B2 (ja) | 2022-05-20 |
Family
ID=62245543
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511876A Active JP6790304B2 (ja) | 2017-05-19 | 2018-05-11 | Ｂｔｌａアゴニスト抗体およびその使用 |
| JP2020184527A Active JP7072622B2 (ja) | 2017-05-19 | 2020-11-04 | Ｂｔｌａアゴニスト抗体およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511876A Active JP6790304B2 (ja) | 2017-05-19 | 2018-05-11 | Ｂｔｌａアゴニスト抗体およびその使用 |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US10604573B2 (https=) |
| EP (1) | EP3625257A1 (https=) |
| JP (2) | JP6790304B2 (https=) |
| KR (3) | KR102294051B1 (https=) |
| CN (3) | CN117402244A (https=) |
| AR (1) | AR111752A1 (https=) |
| AU (2) | AU2018269585B2 (https=) |
| BR (1) | BR112019021547A2 (https=) |
| CA (2) | CA3064518A1 (https=) |
| CL (1) | CL2019003215A1 (https=) |
| CO (1) | CO2019012756A2 (https=) |
| CR (1) | CR20190521A (https=) |
| DO (1) | DOP2019000293A (https=) |
| EA (1) | EA201992460A1 (https=) |
| EC (1) | ECSP19082184A (https=) |
| JO (1) | JOP20190261A1 (https=) |
| MA (1) | MA49133A (https=) |
| MX (1) | MX381033B (https=) |
| MY (2) | MY198277A (https=) |
| NZ (1) | NZ758360A (https=) |
| PE (1) | PE20191843A1 (https=) |
| PH (1) | PH12019502575A1 (https=) |
| SA (1) | SA519410534B1 (https=) |
| TW (4) | TWI804044B (https=) |
| WO (1) | WO2018213113A1 (https=) |
| ZA (1) | ZA201906954B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201820554D0 (en) * | 2018-12-17 | 2019-01-30 | Univ Oxford Innovation Ltd | BTLA antibodies |
| CN114555792A (zh) | 2019-10-15 | 2022-05-27 | 伊莱利利公司 | 重组改造的、脂肪酶/酯酶缺陷型哺乳动物细胞系 |
| GB202008860D0 (en) * | 2020-06-11 | 2020-07-29 | Univ Oxford Innovation Ltd | BTLA antibodies |
| JP2023546713A (ja) * | 2020-10-23 | 2023-11-07 | アナプティスバイオ インコーポレイティッド | Ｂ及びｔリンパ球アテニュエータ（ｂｔｌａ）調節因子及びその使用方法 |
| US20250304693A1 (en) * | 2022-01-29 | 2025-10-02 | Hifibio, Inc. | Anti-btla antibodies and uses thereof in treating cancer |
| WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
| WO2024243594A1 (en) * | 2023-05-25 | 2024-11-28 | Anaptysbio, Inc. | Btla agonist for mudulation of dendritic cells |
| WO2026053130A1 (en) * | 2024-09-03 | 2026-03-12 | Mirobio Limited | Anti-btla antibodies and uses of the same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8546541B2 (en) | 2002-06-20 | 2013-10-01 | Washington University | Compositions and methods for modulating lymphocyte activity |
| EP1560593B1 (en) * | 2002-10-25 | 2016-04-20 | Genentech, Inc. | Novel composition and methods for the treatment of immune related diseases |
| EP2097447A4 (en) * | 2006-11-15 | 2010-12-29 | Medarex Inc | HUMAN MONOCLONAL ANTIBODIES AGAINST BTLA AND METHODS OF USE |
| BR112012007875A2 (pt) * | 2009-07-31 | 2016-11-22 | Medarex Inc | anticorpos totalmente humanos para btla |
| US9533039B2 (en) * | 2010-09-27 | 2017-01-03 | Regeneron Pharmaceuticals, Inc. | Methods of treating systemic lupus erythematosus (SLE) using anti-CD48 antibodies |
| WO2014018931A1 (en) * | 2012-07-26 | 2014-01-30 | The General Hospital Corporation | Methods and compositions for treating autoimmune disease |
| WO2014183885A1 (en) * | 2013-05-17 | 2014-11-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Antagonist of the btla/hvem interaction for use in therapy |
| EP3288587A4 (en) * | 2015-04-29 | 2018-09-12 | Sanford-Burnham Medical Research Institute | Modulation of immune response using btla agonist antibodies |
| EP3383908A1 (en) * | 2015-12-02 | 2018-10-10 | Stsciences, Inc. | Antibodies specific to glycosylated btla (b- and t- lymphocyte attenuator) |
-
2017
- 2017-06-16 JO JOP/2019/0261A patent/JOP20190261A1/ar unknown
-
2018
- 2018-05-03 AR ARP180101158A patent/AR111752A1/es not_active Application Discontinuation
- 2018-05-04 TW TW110141711A patent/TWI804044B/zh not_active IP Right Cessation
- 2018-05-04 TW TW108133289A patent/TWI747043B/zh not_active IP Right Cessation
- 2018-05-04 TW TW112116965A patent/TW202334237A/zh unknown
- 2018-05-04 TW TW107115166A patent/TWI677504B/zh not_active IP Right Cessation
- 2018-05-11 CA CA3064518A patent/CA3064518A1/en active Pending
- 2018-05-11 CN CN202311364321.5A patent/CN117402244A/zh active Pending
- 2018-05-11 US US15/977,003 patent/US10604573B2/en active Active
- 2018-05-11 KR KR1020197033639A patent/KR102294051B1/ko active Active
- 2018-05-11 MA MA049133A patent/MA49133A/fr unknown
- 2018-05-11 CR CR20190521A patent/CR20190521A/es unknown
- 2018-05-11 MY MYPI2021007625A patent/MY198277A/en unknown
- 2018-05-11 NZ NZ758360A patent/NZ758360A/en not_active IP Right Cessation
- 2018-05-11 PE PE2019002417A patent/PE20191843A1/es unknown
- 2018-05-11 EA EA201992460A patent/EA201992460A1/ru unknown
- 2018-05-11 KR KR1020217026470A patent/KR20210106033A/ko not_active Ceased
- 2018-05-11 AU AU2018269585A patent/AU2018269585B2/en active Active
- 2018-05-11 BR BR112019021547-6A patent/BR112019021547A2/pt unknown
- 2018-05-11 MY MYPI2019006702A patent/MY197425A/en unknown
- 2018-05-11 WO PCT/US2018/032218 patent/WO2018213113A1/en not_active Ceased
- 2018-05-11 KR KR1020227039792A patent/KR20220158847A/ko not_active Ceased
- 2018-05-11 EP EP18727622.5A patent/EP3625257A1/en active Pending
- 2018-05-11 CN CN202311364322.XA patent/CN117402245A/zh active Pending
- 2018-05-11 CA CA3184628A patent/CA3184628A1/en active Pending
- 2018-05-11 MX MX2019013604A patent/MX381033B/es unknown
- 2018-05-11 JP JP2020511876A patent/JP6790304B2/ja active Active
- 2018-05-11 CN CN201880033180.XA patent/CN110621699B/zh active Active
-
2019
- 2019-10-22 ZA ZA2019/06954A patent/ZA201906954B/en unknown
- 2019-11-08 CL CL2019003215A patent/CL2019003215A1/es unknown
- 2019-11-12 SA SA519410534A patent/SA519410534B1/ar unknown
- 2019-11-15 DO DO2019000293A patent/DOP2019000293A/es unknown
- 2019-11-15 CO CONC2019/0012756A patent/CO2019012756A2/es unknown
- 2019-11-18 PH PH12019502575A patent/PH12019502575A1/en unknown
- 2019-11-18 EC ECSENADI201982184A patent/ECSP19082184A/es unknown
-
2020
- 2020-02-17 US US16/792,396 patent/US11396545B2/en active Active
- 2020-11-04 JP JP2020184527A patent/JP7072622B2/ja active Active
-
2021
- 2021-12-02 AU AU2021277743A patent/AU2021277743A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021019642A5 (https=) | ||
| JP2021151253A5 (https=) | ||
| JP2023538891A5 (https=) | ||
| JP2020018311A5 (https=) | ||
| AR120511A2 (es) | Producción de proteínas heteromultiméricas | |
| Xu et al. | Progress, challenges and solutions of research on photosynthetic carbon sequestration efficiency of microalgae | |
| Deska et al. | Immobilized fungal laccase as" green catalyst" for the decolourization process–State of the art | |
| JP2022503959A5 (https=) | ||
| JP2025508827A5 (https=) | ||
| RU2015148746A (ru) | Новый способ клонирования, экспрессии и очистки для получения ранибизумаба | |
| JP2005120106A5 (https=) | ||
| JP2010516239A5 (https=) | ||
| CA2466629A1 (en) | Expression control using variable intergenic sequences | |
| JP2008500050A5 (https=) | ||
| HRP20180155T1 (hr) | Novo protutijelo protiv ljudskog ngf | |
| JP2011024493A5 (https=) | ||
| JP2025090679A5 (https=) | ||
| JP2020509763A5 (https=) | ||
| DE502006009060D1 (de) | Verfahren zur fermentativen Herstellung von Antikörpern | |
| JP2024523166A5 (https=) | ||
| JP2011505811A5 (https=) | ||
| CN103184229A (zh) | 重组蛋白a/g基因及其表达产物的制备、应用 | |
| CN102967523A (zh) | 一种利用石英晶体微天平检测可卡因的方法 | |
| CN115850507A (zh) | 一种正交、双组份蛋白质自组装偶联体系及其构建方法 | |
| CN111334511B (zh) | 一种特异性识别牛妊娠相关糖蛋白的核酸适配体及其应用 |